Therapeutic potential of lung epithelial progenitor cells derived from embryonic and induced pluripotent stem cells

Annual Review of Medicine

Volumn 62, Issue , 2011, Pages 95-105

  Wetsel, Rick A ^a,b   Wang, Dachun ^a   Calame, Daniel G ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

alpha 1 antitrypsin deficiency; bioengineering; COPD; cystic fibrosis; surfactant protein deficiency

Indexed keywords

ANTIBIOTIC G 418; BLEOMYCIN; KRUPPEL LIKE FACTOR 4; NEOMYCIN; OCTAMER TRANSCRIPTION FACTOR 4; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR SOX2;

ACUTE LUNG INJURY; ARTICLE; BIOENGINEERING; BRONCHOMALACIA; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; EMBRYONIC STEM CELL; ENGRAFTMENT; FIBROBLAST; GENETIC SELECTION; HUMAN; LUNG ALVEOLUS CELL TYPE 1; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG PARENCHYMA; LUNG TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; ONCOGENE C MYC; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; STABLE TRANSFECTION; STEM CELL TRANSPLANTATION; TERATOMA; TRACHEA; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL CULTURE TECHNIQUES; EMBRYONIC STEM CELLS; EPITHELIAL CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LUNG; LUNG DISEASES; MICE; RATS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 79551586005     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-med-052009-172110     Document Type: Article

References (50)

1. Bowden DH. 1983. Cell turnover in the lung. Am. Rev. Respir. Dis. 128:S46-48
2. Varanou A, Page CP, Minger SL. 2008. Human embryonic stem cells and lung regeneration. Br. J. Pharmacol. 155:316-25
3. Rawlins EL, Okubo T, Que J, et al. 2008. Epithelial stem/progenitor cells in lung postnatal growth, maintenance, and repair. Cold Spring Harb. Symp. Quant. Biol. 73:291-95
4. Borthwick DW, Shahbazian M, Krantz QT, et al. 2001. Evidence for stem-cell niches in the tracheal epithelium. Am. J. Respir. Cell Mol. Biol. 24:662-70
5. Chen H, Matsumoto K, Stripp BR. 2009. Bronchiolar progenitor cells. Proc. Am. Thorac. Soc. 6:602-6
6. Snyder JC, Teisanu RM, Stripp BR. 2009. Endogenous lung stem cells and contribution to disease. J. Pathol. 217:254-64
7. Reynolds SD, Hong KU, Giangreco A, et al. 2000. Conditional Clara cell ablation reveals a self-renewing progenitor function of pulmonary neuroendocrine cells. Am. J. Physiol. Lung Cell Mol. Physiol. 278:L1256- 63
8. Kim CF, Jackson EL, Woolfenden AE, et al. 2005. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121:823-35
9. Nolen-Walston RD, Kim CF, Mazan MR, et al. 2008. Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration. Am. J. Physiol. Lung Cell Mol. Physiol. 294:L1158-65
10. Rawlins EL, Clark CP, Xue Y, et al. 2009. The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells. Development 136:3741-45
11. Reddy R, Buckley S, Doerken M, et al. 2004. Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. Am. J. Physiol. Lung Cell Mol. Physiol. 286:L658-67
12. Odorico JS, Kaufman DS, Thomson JA. 2001. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19:193-204
13. Rippon HJ, Lane S, Qin M, et al. 2008. Embryonic stem cells as a source of pulmonary epithelium in vitro and in vivo. Proc. Am. Thorac. Soc. 5:717-22
14. Ali NN, Edgar AJ, Samadikuchaksaraei A, et al. 2002. Derivation of type II alveolar epithelial cells from murine embryonic stem cells. Tissue Eng. 8:541-50
15. Samadikuchaksaraei A, Cohen S, Isaac K, et al. 2006. Derivation of distal airway epithelium from human embryonic stem cells. Tissue Eng. 12:867-75
16. Rippon HJ, Polak JM, Qin M, et al. 2006. Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells 24:1389-98
17. Denham M, Cole TJ, Mollard R. 2006. Embryonic stem cells form glandular structures and express surfactant protein C following culture with dissociated fetal respiratory tissue. Am. J. Physiol. Lung Cell Mol. Physiol. 290:L1210-15
18. Roszell B, Mondrinos MJ, Seaton A, et al. 2009. Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application. Tissue Eng. Part A 15:3351-65
19. Wang D, Haviland DL, Burns AR, et al. 2007. A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 104:4449-54
20. Selman M, King TE, Pardo A. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134:136-51
21. Wang D, Morales JE, Calame DG, et al. 2010. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol. Ther. 18:625-34
22. Gupta N, Su X, Popov B, et al. 2007. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol. 179:1855-63
23. Xu J, Woods CR, Mora AL, et al. 2007. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 293:L131-41
24. Zhao F, Zhang YF, Liu YG, et al. 2008. Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant Proc. 40:1700-5
25. Sueblinvong V, Weiss DJ. 2010. Stem cells and cell therapy approaches in lung biology and diseases. Transl. Res. 156:188-205
26. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-76
27. Takahashi K, Tanabe K, Ohnuki M, et al. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-72
28. Yu J, Vodyanik MA, Smuga-Otto K, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-20
29. Osafune K, Caron L, Borowiak M, et al. 2008. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26:313-15
30. Lengner CJ. 2010. iPS cell technology in regenerative medicine. Ann. NY Acad. Sci. 1192:38-44
31. Zhou H, Wu S, Joo JY, et al. 2009. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem. Cell 4:381-84
32. Yu J, Hu K, Smuga-Otto K, et al. 2009. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324:797-801
33. Yusa K, Rad R, Takeda J, et al. 2009. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat. Methods 6:363-69
34. Woltjen K, Michael IP, Mohseni P, et al. 2009. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458:766-70
35. Kaji K, Norrby K, Paca A, et al. 2009. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458:771-75
36. Kim D, Kim CH, Moon JI, et al. 2009. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472-76
37. Wernig M, Zhao JP, Pruszak J, et al. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105:5856-61
38. Alipio Z, Liao W, Roemer EJ, et al. 2010. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc. Natl. Acad. Sci. USA 107:13426-31
39. Hanna J, Wernig M, Markoulaki S, et al. 2007. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-23
40. Somers A, Jean JC, Sommer CA, et al. 2010. Generation of transgene-free lung disease-specific human iPS cells using a single excisable lentiviral stem cell cassette. Stem Cells In press
41. Chen P, Marsilio E, Goldstein RH, et al. 2005. Formation of lung alveolar-like structures in collagen-glycosaminoglycan scaffolds in vitro. Tissue Eng. 11:1436-48
42. Cortiella J, Nichols JE, Kojima K, et al. 2006. Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng. 12:1213-25
43. Mondrinos MJ, Koutzaki S, Jiwanmall E, et al. 2006. Engineering three-dimensional pulmonary tissue constructs. Tissue Eng. 12:717-28
44. Andrade CF, Wong AP, Waddell TK, et al. 2007. Cell-based tissue engineering for lung regeneration. Am. J. Physiol. Lung Cell Mol. Physiol. 292:L510-18
45. Mondrinos MJ, Koutzaki SH, Poblete HM, et al. 2008. In vivo pulmonary tissue engineering: contribution of donor-derived endothelial cells to construct vascularization. Tissue Eng. Part A 14:361-68
46. Macchiarini P, Jungebluth P, Go T, et al. 2008. Clinical transplantation of a tissue-engineered airway. Lancet 372:2023-30
47. Sato T, Tao H, Araki M, et al. 2008. Replacement of the left main bronchus with a tissue-engineered prosthesis in a canine model. Ann. Thorac. Surg. 86:422-28
48. Cortiella J, Niles J, Cantu A, et al. 2010. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng. Part A 16:2565-80
49. Petersen TH, Calle EA, Zhao L, et al. 2010. Tissue-engineered lungs for in vivo implantation. Science 329:538-41
50. Osiris Therapeutics, Inc. 2010. Osiris therapeutics reports interim data for COPD stem cell study. Press release. Available at http://investor.osiris. com/releasedetail.cfm?ReleaseID=391580